Interleukin 17a Antikörper
Kurzübersicht für Interleukin 17a Antikörper (ABIN7670182)
Target
Alle Interleukin 17a (IL17A) Antikörper anzeigenReaktivität
Wirt
Klonalität
Konjugat
Applikation
Klon
-
-
Verwendungszweck
- AF/LE Purified Anti-Mouse IL-17A Antibody[17F3]
-
Endotoxin-Niveau
- Low Endotoxin
-
Isotyp
- IgG1, kappa
-
-
-
-
Applikationshinweise
- Optimal working dilution should be determined by the investigator.
-
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Konzentration
- ≥ 1 mg/mL
-
Buffer
- Sterile PBS. < 1.0 EU per mg of the antibody as determined by the LAL method.
-
Konservierungsmittel
- Azide free
-
Handhabung
- avoid freeze / thaw cycles. This preparation contains no preservatives, thus it should be handled under aseptic conditions.
-
Lagerung
- 4 °C,-20 °C
-
Informationen zur Lagerung
- Store at 4°C valid for 12 months or -20°C valid for long term storage, avoid freeze / thaw cycles. This preparation contains no preservatives, thus it should be handled under aseptic conditions.
-
Haltbarkeit
- 12 months
-
-
- Interleukin 17a (IL17A) (Interleukin 17A (IL17A))
-
Andere Bezeichnung
- IL-17A
-
Hintergrund
- Interleukin-17A,Il17a,Ctla9,The 17F3 monoclonal antibody reacts with mouse IL-17A a 15-20 kDa cytokine expressed by Th17 cells, γδ T cells, iNKT cells, NK cells, LTi cells, neutrophils, and intestinal Paneth cells. IL-17A has pleiotropic effects in immunoregulation and inflammation. It plays an important role in anti-microbial and chronic inflammation by inducing cytokine and chemokine production, neutrophil influx, and the production of antibacterial peptides but it is also an inflammatory mediator in the development of autoimmune diseases including rheumatoid arthritis, asthma, multiple sclerosis, and psoriasis. The 17F3 antibody has been shown to neutralize IL-18A?in vivo.
-
UniProt
- Q62386
Target
-